Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
LUCD
#3508
Lucid Diagnostics Inc. Common Stock
1.4
1
USD
+4.44%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+4.44%
Changement Mensuel
+0.71%
Evolution sur 6 mois
+12.80%
Changement Annuel
+24.78%
Clôture Précédente
1.3
5
Open
1.4
1
Bid
Ask
Low
1.4
1
High
1.4
1
Volume
25
Marchés
Actions des Marchés US
Soins de Santé
LUCD
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
90.75 M
90.96 M
108.41 M
137.51 M
176.95 M
—
Valuation ratios
Enterprise value
127.62 M
199.98 M
175.52 M
170.16 M
238.26 M
783.92 M
Price to earnings ratio
-0.78
-1.27
-1.13
-1.16
-1.92
-5.48
Price to sales ratio
9.52
18.8
16.26
17.21
23.61
75.89
Price to cash flow ratio
-0.94
-1.82
-1.68
-1.73
-2.39
-7.62
Price to book ratio
-0.84
-0.41
-0.35
-0.39
-2.56
-3.71
Enterprise value to EBITDA ratio
-2.84
-4.27
-3.73
-3.61
-4.89
-16.49
Profitability ratios
Return on assets %
-0.38
-0.82
-0.11
-0.2
-0.4
-1.53
Return on equity %
-2.14
5
-0.56
-0.4
-1.49
2.55
Return on invested capital %
-223.33
-150.36
-122.36
-151.14
-197.74
-621.61
Gross margin %
100
100
100
100
—
—
Operating margin %
-1 033.75
-1 508.09
-978.85
-971.02
—
—
EBITDA margin %
-1 015.2
-1 481.4
-959.76
-952.85
—
—
Net margin %
-964.16
-3 249.76
-381.69
-858.55
—
—
Liquidity ratios
Quick ratio
1.05
0.74
1.13
1.88
1.3
5.05
Current ratio
1.07
0.75
1.15
1.9
1.31
5.12
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.03
0.03
0.03
0
0.08
Solvency ratios
Debt to assets ratio
0.69
1.08
0.71
0.46
0.64
2.88
Debt to equity ratio
3.94
-6.56
3.5
0.94
2.36
0.25
Long term debt to total assets ratio
0.61
1
0.65
0.42
0.59
2.67
Long term debt to total equity ratio
3.45
-6.1
3.22
0.86
2.19
0.18
Per share metrics
Operating cash flow per share
-0.2
-0.18
-0.11
-0.1
-0.12
-0.51
EBIT per share
-0.24
-0.18
-0.12
-0.11
-0.07
-0.47
EBITDA per share
-0.24
-0.18
-0.11
-0.11
-0.07
-0.46
Total debt per share
0.42
0.51
0.28
0.22
0.25
1.27
Cash per share
0.44
0.37
0.31
0.44
0.34
1.46
Net current asset value per share
0.5
0.4
0.34
0.46
0.37
1.57
Tangible book value per share
-0.99
-0.88
-0.48
-0.27
-0.43
-2.05
Working capital per share
0.03
-0.13
0.04
0.22
0.09
0.22
Book value per share
-0.97
-0.87
-0.47
-0.26
-0.43
-2.03
Nouvelles
BTIG réitère sa recommandation sur Lucid Diagnostics après des résultats T4 supérieurs aux attentes
Lucid Diagnostics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:LUCD) 2026-03-27
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript
Needham réitère sa recommandation d’achat sur Lucid Diagnostics, objectif de 3$
Lucid Diagnostics : l’action grimpe malgré un BPA manqué au T4 2025
Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
Lucid Diagnostics annonce un chiffre d’affaires de 1,5 M$ au T4 et un contrat avec le VA
Canaccord réitère sa recommandation d’achat sur Lucid Diagnostics, objectif de 3$
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates